1-3 of 3
Claudia Seelenmeyer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation

Lucía Cespón Torrado, Koen Temmerman, Hans-Michael Müller, Matthias P. Mayer, Claudia Seelenmeyer, Rafael Backhaus, Walter Nickel
Journal: Journal of Cell Science
J Cell Sci (2009) 122 (18): 3322–3329.
https://doi.org/10.1242/jcs.049791
Published: 15 September 2009
View article titled, An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation
Open the PDF for An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation in another window
Journal Articles

The cancer antigen CA125 represents a novel counter receptor for galectin-1

Claudia Seelenmeyer, Sabine Wegehingel, Johannes Lechner, Walter Nickel
Journal: Journal of Cell Science
J Cell Sci (2003) 116 (7): 1305–1318.
https://doi.org/10.1242/jcs.00312
Published: 1 April 2003
View article titled, The cancer antigen CA125 represents a novel counter receptor for galectin-1
Open the PDF for The cancer antigen CA125 represents a novel counter receptor for galectin-1 in another window
Journal Articles

Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells

André Engling, Rafael Backhaus, Carolin Stegmayer, Christoph Zehe, Claudia Seelenmeyer, Angelika Kehlenbach, Blanche Schwappach, Sabine Wegehingel, Walter Nickel
Journal: Journal of Cell Science
J Cell Sci (2002) 115 (18): 3619–3631.
https://doi.org/10.1242/jcs.00036
Published: 15 September 2002
View article titled, Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells
Open the PDF for Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells in another window